RxDoctor Payments Data

Taylor Fahey

Family · Liverpool, NYNPI 1477368629

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 75 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 16.9% — the pattern of someone who eats at a lot of different presentations.

$1,387in general payments, 2019–2025

Across 75 payments — averaging $18.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$234
  • AstraZeneca$156
  • Bayer$143
  • AbbVie$88
  • Lilly USA, LLC$82
  • Otsuka America Pharmaceutical, Inc.$69
  • plus $615 from 20 others

What the payments were for

  • Food & beverage$1,387100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,387 in reported general payments places this provider in the 75th percentile of 8,883 family providers in New York.

See all family providers in New York →

Other family in Liverpool

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →